Enrico Amico Centre for Neurogenetics and Rare Diseases IRCCS Neuromed Biography Publications Institution JoVE Articles Enrico Amico has not added a biography. If you are Enrico Amico and would like to personalize this page please email our Author Liaison for assistance. Publications Defective Sphingosine-1-phosphate Metabolism is a Druggable Target in Huntington's Disease Scientific Reports. Jul, 2017 | Pubmed ID: 28706199 Impairment of Blood-brain Barrier is an Early Event in R6/2 Mouse Model of Huntington Disease Scientific Reports. Jan, 2017 | Pubmed ID: 28117381 Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models Frontiers in Neuroscience. 2016 | Pubmed ID: 27766070 Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease CNS Neuroscience & Therapeutics. Aug, 2016 | Pubmed ID: 27225886 Pridopidine, a Dopamine Stabilizer, Improves Motor Performance and Shows Neuroprotective Effects in Huntington Disease R6/2 Mouse Model Journal of Cellular and Molecular Medicine. Nov, 2015 | Pubmed ID: 26094900 Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease PloS One. 2014 | Pubmed ID: 24587005 FTY720 (fingolimod) is a Neuroprotective and Disease-modifying Agent in Cellular and Mouse Models of Huntington Disease Human Molecular Genetics. May, 2014 | Pubmed ID: 24301680 Changes of Peripheral TGF-β1 Depend on Monocytes-derived Macrophages in Huntington Disease Molecular Brain. Dec, 2013 | Pubmed ID: 24330808 Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease Journal of Cellular and Molecular Medicine. Mar, 2011 | Pubmed ID: 20082658 Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease Alba Di Pardo1, Salvatore Castaldo1, Luca Capocci1, Enrico Amico1, Vittorio Maglione1 1Centre for Neurogenetics and Rare Diseases, IRCCS Neuromed JoVE 56389 Neuroscience
Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease Alba Di Pardo1, Salvatore Castaldo1, Luca Capocci1, Enrico Amico1, Vittorio Maglione1 1Centre for Neurogenetics and Rare Diseases, IRCCS Neuromed JoVE 56389 Neuroscience
